Search

everythinglearnresearchcommunity

for

Search:↓

Taking He Shou Wu (Polygonum multiflorum) caused liver injury in a woman using it for hair loss.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Anabolic steroids and SARMs can cause serious liver damage.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Shen-Min, a hair growth supplement, likely caused acute hepatitis in a woman, improving after she stopped taking it.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Interferon therapy improves quality of life for chronic hepatitis B patients.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

A woman's liver problems improved after she stopped taking spironolactone.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Sphaeranthus indicus and silver nanoparticles can help treat liver cancer by killing cancer cells.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Hepatitis C can clear naturally in some people due to strong immune response, genetics, and limited exposure.

Excessive selenium intake can cause liver damage.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.